Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination/Group D"
From Testiwiki
(Created page with "Category:DARM exercise == Pandemrix should not be used because of narcolepsy risk == {{discussion |Statements= Pandemrix should not be used any more anywhere because its nar...") |
Carmen Gil (talk | contribs) (→Pandemrix should not be used because of narcolepsy risk) |
||
| Line 7: | Line 7: | ||
|Argumentation = | |Argumentation = | ||
{{attack|1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} | {{attack|1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} | ||
| + | :{{attack|# |Side effects are still there and will be treated poorly in these countries|--[[User:Carmen Gil|Carmen Gil]] 11:25, 1 April 2011 (EEST)}} | ||
| + | {{comment|# |The decision to use Pandemrix was probably led by panic and other choices should be considered at this point|--[[User:Carmen Gil|Carmen Gil]] 11:25, 1 April 2011 (EEST)}} | ||
| + | ::{{defend|# |Finland used a vaccination with additives, against the recommendation of WHO|--[[User:Carmen Gil|Carmen Gil]] 11:25, 1 April 2011 (EEST)}} | ||
| + | :::{{defend|# |Additives can cause flu-like symptoms, increasing the public's opinion against vaccination|--[[User:Carmen Gil|Carmen Gil]] 11:25, 1 April 2011 (EEST)}} | ||
| + | {{defend|2 |The reputation of Pandemrix is globally so poor that it is impossible to use it any more.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} | ||
| + | {{defend|3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}} | ||
| − | {{ | + | {{attack|# |Pandemrix has a lower Hg content than other vaccines (2.5 vs 25 µg), which could cause other neurological problems in children|--[[User:Carmen Gil|Carmen Gil]] 11:25, 1 April 2011 (EEST)}} |
| − | |||
}} | }} | ||
| − | |||
*[http://whqlibdoc.who.int/publications/2010/9789241599924_eng.pdf Evolution of a pandemic, World Health Organization (WHO), 2009 (Report)] | *[http://whqlibdoc.who.int/publications/2010/9789241599924_eng.pdf Evolution of a pandemic, World Health Organization (WHO), 2009 (Report)] | ||
*[http://www.rokotusinfo.fi/rokotteet/sikainfluenssa_html] | *[http://www.rokotusinfo.fi/rokotteet/sikainfluenssa_html] | ||
*[http://www.ktl.fi/portal/suomi/osastot/vimo/tutkimus-_ja_seurantakohteet/influenssa/influenssan_seuranta/#navi0] | *[http://www.ktl.fi/portal/suomi/osastot/vimo/tutkimus-_ja_seurantakohteet/influenssa/influenssan_seuranta/#navi0] | ||
Revision as of 08:25, 1 April 2011
Pandemrix should not be used because of narcolepsy risk
| Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
| Argumentation:
⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST)
--# : The decision to use Pandemrix was probably led by panic and other choices should be considered at this point --Carmen Gil 11:25, 1 April 2011 (EEST)
←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST) ←3 : In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1] ⇤# : Pandemrix has a lower Hg content than other vaccines (2.5 vs 25 µg), which could cause other neurological problems in children --Carmen Gil 11:25, 1 April 2011 (EEST) |
